- Home
- RBA vs NBIX Comparison
RBA vs NBIX Comparison
Compare RBA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBA
- NBIX
- Stock Information
- Founded
- RBA 1958
- NBIX 1992
- Country
- RBA United States
- NBIX United States
- Employees
- RBA N/A
- NBIX N/A
- Industry
- RBA Business Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RBA Consumer Discretionary
- NBIX Health Care
- Exchange
- RBA Nasdaq
- NBIX Nasdaq
- Market Cap
- RBA 15.5B
- NBIX 13.7B
- IPO Year
- RBA 1998
- NBIX 1996
- Fundamental
- Price
- RBA $91.48
- NBIX $138.85
- Analyst Decision
- RBA Buy
- NBIX Buy
- Analyst Count
- RBA 6
- NBIX 22
- Target Price
- RBA $98.92
- NBIX $166.29
- AVG Volume (30 Days)
- RBA 819.3K
- NBIX 953.5K
- Earning Date
- RBA 11-08-2024
- NBIX 02-05-2025
- Dividend Yield
- RBA 1.28%
- NBIX N/A
- EPS Growth
- RBA 90.23
- NBIX 97.40
- EPS
- RBA 1.84
- NBIX 3.73
- Revenue
- RBA $4,183,500,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- RBA $15.69
- NBIX $27.07
- Revenue Next Year
- RBA $4.42
- NBIX $16.60
- P/E Ratio
- RBA $49.39
- NBIX $36.62
- Revenue Growth
- RBA 35.71
- NBIX 25.72
- 52 Week Low
- RBA $60.84
- NBIX $110.95
- 52 Week High
- RBA $99.79
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- RBA 38.58
- NBIX 67.03
- Support Level
- RBA $90.13
- NBIX $132.83
- Resistance Level
- RBA $91.02
- NBIX $138.12
- Average True Range (ATR)
- RBA 1.30
- NBIX 3.13
- MACD
- RBA -0.92
- NBIX 0.50
- Stochastic Oscillator
- RBA 10.04
- NBIX 73.59
About RBA RB Global Inc.
RB Global operates the world's largest auction for heavy equipment. The company started as a live auctioneer of industrial equipment; since then it has greatly expanded its operations to include the sale of construction, agricultural, oilfield, and transportation equipment. RB Global operates over 40 live auction sites in more than 12 countries, along with online marketplaces, including IronPlanet, Marketplace-E, and GovPlanet. Its agricultural auctions are frequently much smaller venues and can include liquidations of single farms. The company holds over 300 auctions yearly and sells $6 billion worth of equipment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.